Edition:
United Kingdom

OvaScience Inc (OVAS.OQ)

OVAS.OQ on NASDAQ Stock Exchange Global Market

1.38USD
11 Dec 2017
Change (% chg)

$-0.02 (-1.43%)
Prev Close
$1.40
Open
$1.40
Day's High
$1.41
Day's Low
$1.38
Volume
24,598
Avg. Vol
38,669
52-wk High
$3.24
52-wk Low
$1.26

Latest Key Developments (Source: Significant Developments)

Ovascience reports Q3 loss per share $0.26
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Ovascience Inc :Ovascience reports third quarter 2017 financial results.Q3 loss per share $0.26.Q3 earnings per share view $-0.40 -- Thomson Reuters I/B/E/S.Ovascience Inc - ‍expects to incur additional cash outlays related to restructurings of between $1.0 million and $1.5 million over 2017 and 2018​.Ovascience Inc - ‍anticipates that it will have sufficient funds without additional financing to support its operations into q1 of 2020​.  Full Article

Ovascience names Christophe Couturier as CFO
Tuesday, 6 Sep 2016 

Ovascience Inc : Christophe Couturier has been named chief financial officer, effective immediately .Christophe couturier succeeds Jeff Young, who is pursuing other opportunities and will be leaving ovascience after a transition period.  Full Article

Ovascience Q2 loss per share $0.62
Thursday, 4 Aug 2016 

Ovascience Inc : Q2 earnings per share view $-0.78 -- Thomson Reuters I/B/E/S . Ovascience reports second quarter 2016 financial results . Q2 loss per share $0.62 .Ovascience reports second quarter 2016 financial results.  Full Article

Ovascience says offering of 7.2 mln shares priced at $7/share
Thursday, 26 May 2016 

Ovascience Inc : Ovascience announces pricing of public offering of common stock .Says priced its previously announced underwritten public offering of 7.2 million shares of its common stock at $7.00 per share.  Full Article

Ovascience says commenced public offering of common stock
Wednesday, 25 May 2016 

Ovascience Inc : To use proceeds to fund commercial expansion of augment treatment in key regions, ongoing pre-commercial activities for Ovaprime .Ovascience announces proposed public offering of common stock.  Full Article

Ovascience director Richard Aldrich reports purchase of stock
Friday, 20 May 2016 

Ovascience Inc : Director Richard Aldrich reports purchase of 20,000 shares of co's common stock on May 18 at average price $7.86 per share - sec filing .Director Aldrich's purchase of co's stock reflects purchase of the shares by Longwood Fund III LP, according to form 4 filing.  Full Article

Ovascience Inc announces leadership changes
Wednesday, 6 Jan 2016 

Ovascience Inc:Names Harald F. stock chief executive officer-elect.Harald F. Stock, will succeed Michelle Dipp, as CEO, effective July 1, 2016.Michelle Dipp has been appointed executive Chairman of the board, and she will remain CEO until July 1.  Full Article

BRIEF-Ovascience reports Q3 loss per share $0.26

* Q3 earnings per share view $-0.40 -- Thomson Reuters I/B/E/S